Report cover image

Theratechnologies Inc - Strategic SWOT Analysis Review

Publisher GlobalData
Published Feb 27, 2026
Length 51 Pages
SKU # GBDT20940208

Description

Theratechnologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Theratechnologies Inc (Theratechnologies) is a biopharmaceutical company that focuses on the discovery and development of drugs for people with orphan medical conditions. The company’s marketed products include Egrifta SV, which is indicated to reduce excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a CD-4 directed post-attachment HIV-1 inhibitor indicated for HIV type 1 infection in the US. Its pipeline products include Trogarzo IV slow push for HIV and Egrifta F8 for NASH HIV. The company is also developing TH 1902 for triple-negative breast cancer and TH1904 for ovarian cancer. It develops products based on peptide stabilisation technology to increase target protein resistance to enzymatic degradation. Theratechnologies is headquartered in Montreal, Quebec, Canada.

Theratechnologies Inc Key Recent Developments

Jul 03,2025: Theratechnologies to Announce Second Quarter 2025 Financial Results
Apr 09,2025: Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
Apr 03,2025: Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
Mar 12,2025: Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People With HIV

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

51 Pages
Section 1 - About the Company
Theratechnologies Inc - Key Facts
Theratechnologies Inc - Key Employees
Theratechnologies Inc - Key Employee Biographies
Theratechnologies Inc - Major Products and Services
Theratechnologies Inc - History
Theratechnologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Theratechnologies Inc - Business Description
Product Category: Egrifta SV
Performance
Product Category: Trogarzo
Performance
Geographical Segment: Europe
Performance
Geographical Segment: USA
Performance
R&D Overview
Theratechnologies Inc - Corporate Strategy
Theratechnologies Inc - SWOT Analysis
SWOT Analysis - Overview
Theratechnologies Inc - Strengths
Theratechnologies Inc - Weaknesses
Theratechnologies Inc - Opportunities
Theratechnologies Inc - Threats
Theratechnologies Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Theratechnologies Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jul 03, 2025: Theratechnologies to Announce Second Quarter 2025 Financial Results
Apr 09, 2025: Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
Apr 03, 2025: Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
Mar 12, 2025: Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People With HIV
Feb 26, 2025: Theratechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 26, 2025: Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
Feb 14, 2025: Theratechnologies to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Business Update
Feb 14, 2025: Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Jan 10, 2025: World Orphan Drug Alliance Expands to Canada and Full Latam Region, Completing the First Truly Global Commercialization Offering
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Theratechnologies Inc, Key Facts
Theratechnologies Inc, Key Employees
Theratechnologies Inc, Key Employee Biographies
Theratechnologies Inc, Major Products and Services
Theratechnologies Inc, History
Theratechnologies Inc, Other Locations
Theratechnologies Inc, Subsidiaries
Theratechnologies Inc, Key Competitors
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Theratechnologies Inc, Recent Deals Summary
List of Figures
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.